pharmaphorum Top Stories 2 September 2024
pharmaphorum
Industry leading publications, strategic consulting and a content-driven stakeholder engagement agency
This week’s Top Stories from pharmaphorum is all about market access.
Pfizer is following Lilly into the direct-to-consumer fray, while Lily looks for ways to make its GLP-1s easier to get. Meanwhile, Johnson & Johnson wants to take proactive action against Medicare 340B abuse for its two IRA-affected drugs, but government agencies aren’t having it.
All this and more in this week’s Top Stories – dig in below.
Top Stories
Pfizer joins Lilly in direct-to-consumer drive
辉瑞 has become the latest big pharma group to launch a web-based platform that opens up a direct-to-consumer channel for medicines access. READ MORE
J&J's bid to change pay model for Stelara, Xarelto slammed
A US government agency has hit back at a plan by 强生公司 to change the way it pays discounts on drugs to hospitals participating in the 340B programme for healthcare systems serving vulnerable populations. READ MORE
Lilly launches single-dose Zepbound to ease self-pay access
礼来 has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound in a move that it said would make it easier for people paying for the drug out-of-pocket to afford treatment. READ MORE
Women's health DTx developer Curio raises funds for PPD app
Digital therapeutics (DTx) developer Curio has raised over $10 million in first-round financing that will be used to fund the rollout of its MamaLift Plus app for postpartum depression (PPD). READ MORE
领英推荐
Bayer takes lung cancer therapy hope into phase 3
拜耳 has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, one of the drugs central to the company’s plan to become a top player in oncology by the end of the decade. READ MORE
Webinars | Live advice from pharma and biotech luminaries
Unlocking the Power of Storytelling in Medical Publications
Join us on September 18th at 10am ET – 3pm BST – 4pm CEST to find out why storytelling is vitally important and its definition within the scientific publications landscape. MORE
Shifting the paradigm in pharma marketing with content transformation
Join us on September 25 at 12pm EST, 5pm BST for this engaging and informative discussion with a noted customer experience and digital transformation expert, who will discuss learnings from her pharmaceutical industry experience at Takeda and Biogen. MORE
Beyond clinical: Boosting recruitment and retention with SDOH data
Join pharmaphorum on Wednesday, October 2nd (1:00pm ET / 10:00am PT / 5:00pm GMT) for a webinar, developed in association with Socially Determined, to discover how industry leaders are harnessing non-clinical data to enhance recruitment, retention, and broader evidence generation. MORE